WallStreetZenWallStreetZen

Stock ScreenerStock IdeasHigh Risk, High Reward
High Risk, High Reward Stocks
Speculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!

Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
Ticker
Company
Performance Score
Market Cap
Revenue
EBITDA
Earnings
EPS
Revenue Growth Y/Y
Revenue Growth 5Y
Earnings Growth Y/Y
Earnings Growth 5Y
Earnings Date
INTZ
INTRUSION INC
$3.85M$5.61M-$10.34M-$13.89M-$11.46-25.47%-11.40%N/AN/A2024-05-15
ASLN
ASLAN PHARMACEUTICALS LTD
$7.30M$12.00M-$39.41M-$44.22M-$2.75N/AN/AN/AN/A2024-04-29
PPBT
PURPLE BIOTECH LTD
$9.72M$0.00$22.27M$19.88MN/AN/A-100.00%N/AN/A2024-05-09
CLDI
CALIDI BIOTHERAPEUTICS INC
$5.72M$0.00-$26.88M-$29.22M-$1.73-100.00%N/AN/AN/A2024-05-29
IQ
IQIYI INC
$4.79B$4.43B$1.48B$267.43M$0.288.05%4.45%N/AN/A2024-05-16
CLNN
CLENE INC
$43.67M$654.00k-$42.81M-$49.50M-$0.4738.27%N/AN/AN/A2024-05-29
LIFE
ATYR PHARMA INC
$106.37M$353.00k-$47.65M-$50.39M-$0.94-96.60%N/AN/AN/A2024-05-22
BPTH
BIO-PATH HOLDINGS INC
$1.82M$0.00-$15.90M-$16.08M-$33.63N/AN/AN/AN/A2024-05-10
BIOL
BIOLASE INC
$4.81M$49.16M-$15.44M-$37.62M-$29.441.45%1.27%N/AN/A2024-05-09
GOEV
CANOO INC
$178.38M$886.00k-$279.28M-$302.62M-$0.53N/AN/AN/AN/A2024-05-13
KZR
KEZAR LIFE SCIENCES INC
$58.61M$7.00M-$99.25M-$101.87M-$1.40N/AN/AN/AN/A2024-06-18
CKPT
CHECKPOINT THERAPEUTICS INC
$51.03M$103.00k-$51.85M-$51.85M-$3.17-46.35%-50.61%N/AN/A2024-05-13
BNED
BARNES & NOBLE EDUCATION INC
$10.58M$1.55B-$10.93M-$82.10M-$1.561.30%-5.55%N/AN/A
GOSS
GOSSAMER BIO INC
$150.69M$0.00-$161.92M-$179.82M-$1.18N/AN/AN/AN/A2024-06-06
APLM
APOLLOMICS INC
$40.27M$0.00-$171.77M-$172.60M-$2.32N/AN/AN/AN/A
APTO
APTOSE BIOSCIENCES INC
$19.18M$0.00-$50.74M-$51.21M-$7.58N/AN/AN/AN/A2024-05-28
OCUP
OCUPHIRE PHARMA INC
$39.95M$19.05M-$9.97M-$9.99M-$0.46-52.20%N/AN/AN/A2024-06-11
AADI
AADI BIOSCIENCE INC
$42.97M$24.35M-$64.90M-$65.77M-$2.4460.06%3.85%N/AN/A2024-06-13
AGEN
AGENUS INC
$244.86M$156.31M-$134.25M-$245.97M-$13.8059.47%33.56%N/AN/A2024-05-07
MVST
MICROVAST HOLDINGS INC
$130.37M$306.62M-$78.01M-$106.34M-$0.3449.94%11.97%N/AN/A2024-06-04
SONN
SONNET BIOTHERAPEUTICS HOLDINGS INC
$5.43M$129.18k-$14.38M-$14.46M-$9.87-49.81%-66.53%N/AN/A2024-05-08
IFRX
INFLARX NV
$78.31M$68.58k-$45.72M-$46.38M-$0.85N/AN/AN/AN/A2024-05-09
YTEN
YIELD10 BIOSCIENCE INC
$3.42M$60.00k-$13.86M-$14.46M-$1.82-86.67%-35.94%N/AN/A2024-06-07
MIST
MILESTONE PHARMACEUTICALS INC
$81.85M$1.00M-$57.04M-$59.69M-$1.39-80.00%N/AN/AN/A2024-06-13
MRNS
MARINUS PHARMACEUTICALS INC
$76.77M$30.99M-$125.31M-$141.41M-$2.6321.63%N/AN/AN/A2024-05-09
VIRX
VIRACTA THERAPEUTICS INC
$32.52M$0.00-$46.86M-$51.06M-$1.32N/A-100.00%N/AN/A2024-06-07
GNLX
GENELUX CORP
$91.34M$170.00k-$27.63M-$28.30M-$1.16-98.46%N/AN/AN/A
IMRX
IMMUNEERING CORP
$43.05M$0.00-$52.71M-$53.47M-$1.88-100.00%N/AN/AN/A2024-05-07
TARA
PROTARA THERAPEUTICS INC
$33.44M$0.00-$40.08M-$40.42M-$3.57N/AN/AN/AN/A2024-05-02
FEMY
FEMASYS INC
$28.07M$1.07M-$13.17M-$14.25M-$0.93-11.13%N/AN/AN/A2024-05-09
GEVO
GEVO INC
$155.60M$17.20M-$45.05M-$66.22M-$0.281,363.83%-12.15%N/AN/A2024-05-21
INAB
IN8BIO INC
$45.02M$0.00-$27.51M-$30.01M-$1.00N/AN/AN/AN/A2024-05-10
EVA
ENVIVA INC
$40.00M$1.13B-$38.24M-$335.35M-$4.89-0.03%14.85%N/AN/A2024-06-14
NTBL
NOTABLE LABS LTD
$8.70M$310.00k-$10.28M-$11.15M-$3.413,775.00%-11.93%N/AN/A2024-05-13
SYBX
SYNLOGIC INC
$21.78M$3.37M-$51.97M-$57.28M-$8.81185.68%5.99%N/AN/A2024-06-14
CVKD
CADRENAL THERAPEUTICS INC
$6.88M$0.00-$8.34M-$8.36M-$0.62N/AN/AN/AN/A
SGMT
SAGIMET BIOSCIENCES INC
$129.57M$2.00M-$27.74M-$27.88M-$2.66N/AN/AN/AN/A
VOR
VOR BIOPHARMA INC
$115.21M$0.00-$109.64M-$117.86M-$1.75N/AN/AN/AN/A2024-05-23
LUMO
LUMOS PHARMA INC
$22.46M$2.05M-$34.02M-$34.03M-$4.1834.67%-30.31%N/AN/A2024-05-31
PRST
PRESTO AUTOMATION INC
$13.65M$21.20M-$48.24M-$66.42M-$1.31-30.61%N/AN/AN/A2024-05-16
SPRB
SPRUCE BIOSCIENCES INC
$28.80M$10.09M-$47.14M-$47.92M-$1.24N/AN/AN/AN/A2024-05-22
MBRX
MOLECULIN BIOTECH INC
$10.31M$0.00-$29.64M-$29.77M-$15.07N/AN/AN/AN/A2024-06-14
GRTS
GRITSTONE BIO INC
$79.73M$16.34M-$112.80M-$138.49M-$1.20-18.05%68.96%N/AN/A2024-06-14
IKNA
IKENA ONCOLOGY INC
$62.74M$9.16M-$65.59M-$68.17M-$1.63-41.35%N/AN/AN/A2024-06-07
FBIO
FORTRESS BIOTECH INC
$33.08M$84.51M-$36.73M-$68.67M-$8.4711.58%25.75%N/AN/A2024-05-23
PASG
PASSAGE BIO INC
$73.39M$0.00-$98.34M-$102.06M-$1.86N/AN/AN/AN/A2024-05-21
PGEN
PRECIGEN INC
$350.98M$6.23M-$89.23M-$95.90M-$0.39-76.87%-47.16%N/AN/A2024-06-07
TPST
TEMPEST THERAPEUTICS INC
$78.56M$0.00-$25.96M-$29.49M-$1.91N/AN/AN/AN/A2024-06-13
PSTX
POSEIDA THERAPEUTICS INC
$205.52M$64.70M-$109.04M-$123.43M-$1.37-50.42%N/AN/AN/A2024-06-14
CMPS
COMPASS PATHWAYS PLC
$509.97M$0.00-$113.21M-$118.46M-$2.32N/AN/AN/AN/A2024-05-09
IVA
INVENTIVA SA
$169.38M$25.18M-$109.06M-$120.03M-$2.6428.59%24.86%N/AN/A2024-05-29
LUXH
LUXURBAN HOTELS INC
$43.07M$113.40M-$35.50M-$78.69M-$2.06158.75%N/AN/AN/A2024-05-07
CARA
CARA THERAPEUTICS INC
$37.38M$20.97M-$115.58M-$118.51M-$2.19-49.92%9.26%N/AN/A2024-06-04
ACET
ADICET BIO INC
$138.02M$0.00-$133.69M-$142.66M-$3.31-100.00%-100.00%N/AN/A2024-06-05
CLRB
CELLECTAR BIOSCIENCES INC
$97.75M$0.00-$37.79M-$37.98M-$3.11N/AN/AN/AN/A2024-06-21
AMPX
AMPRIUS TECHNOLOGIES INC
$159.38M$9.05M-$33.82M-$36.78M-$0.43105.33%N/AN/AN/A2024-05-08
ESPR
ESPERION THERAPEUTICS INC
$351.60M$116.33M-$150.11M-$209.25M-$2.0354.14%N/AN/AN/A2024-05-23
AMLX
AMYLYX PHARMACEUTICALS INC
$119.30M$380.79M$55.39M$49.27M$0.731,612.94%N/AN/AN/A2024-06-06
CMPX
COMPASS THERAPEUTICS INC
$199.50M$0.00-$40.60M-$42.49M-$0.33N/AN/AN/AN/A2024-05-06
OTLK
OUTLOOK THERAPEUTICS INC
$109.70M$0.00-$52.51M-$51.50M-$4.00N/A-100.00%N/AN/A2024-05-13
GLYC
GLYCOMIMETICS INC
$105.70M$10.00k-$35.89M-$36.90M-$0.58-86.67%N/AN/AN/A2024-05-01
VERV
VERVE THERAPEUTICS INC
$515.09M$11.76M-$187.55M-$200.07M-$3.12505.77%N/AN/AN/A2024-05-07
AQMS
AQUA METALS INC
$55.75M$25.00k-$22.05M-$23.94M-$0.25525.00%-64.52%N/AN/A2024-05-23
UBX
UNITY BIOTECHNOLOGY INC
$25.18M$0.00-$36.23M-$39.86M-$2.70-100.00%N/AN/AN/A2024-06-21
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.